KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Jazz Pharmaceuticals (JAZZ) Cost of Revenue (2016 - 2025)

Jazz Pharmaceuticals has reported Cost of Revenue over the past 16 years, most recently at $153.5 million for Q4 2025.

  • Quarterly Cost of Revenue rose 19.28% to $153.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $527.4 million through Dec 2025, up 18.32% year-over-year, with the annual reading at $503.3 million for FY2025, 12.92% up from the prior year.
  • Cost of Revenue was $153.5 million for Q4 2025 at Jazz Pharmaceuticals, up from $128.9 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $167.4 million in Q4 2022 and troughed at $40.2 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $119.2 million (2021), against an average of $119.0 million.
  • Biggest five-year swings in Cost of Revenue: surged 325.57% in 2021 and later tumbled 35.92% in 2023.
  • Tracing JAZZ's Cost of Revenue over 5 years: stood at $136.2 million in 2021, then grew by 22.92% to $167.4 million in 2022, then plummeted by 35.92% to $107.2 million in 2023, then increased by 20.02% to $128.7 million in 2024, then grew by 19.28% to $153.5 million in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $153.5 million, $128.9 million, and $116.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.